Boston Onglyza Lawsuit

For those who, loved one, or even a buddy are looking into submitting claims from the diabetes drug Onglyza (saxagliptin) for causing health complications which have heart failure or departure, then our law firm is more than pleased to offer you help with your Boston Onglyza lawsuit.

Onglyza is a DPP-4 inhibitor, the type of medications made to lower glucose levels and inhibit diabetic complications in adults who have type two diabetes.

In a new FDA advisory committee meeting, it was passed that the tagging used on Onglyza be upgraded together with clear warnings about the risk of developing heart failure. It was a warning that wasn’t included on the drug’s labels before.

For those who, loved one, or relative took Onglyza and suffered heart failure, or your loved one died, you may have grounds for requesting reimbursement against the produces of Onglyza. Understand that AstraZeneca is a massive company and has a team of trusted Mass Tort attorneys representing its own interests once the company is slapped with lawsuits.

Get in contact with our Boston mass tort lawyers to get a free consultation, case review, and also to learn more about your rights.

Table of Contents

What’s Onglyza?

Januvia is just another medication, such as Onglyza, that is used as a treatment for type 2 diabetes. With the increase in insulin levels, the body is able to process glucose (sugars) and be sure they are kept within the normal range.

FDA approved the use of Onglyza after reviewing the outcomes of eight clinical trials achieved by producers AstraZeneca Pharmaceuticals LP. The trial contained safety research meant to demonstrate that Onglyza wasn’t associated with any substantial risk of cardiovascular complications.

However, recent investigations of the outcomes of a clinical trial on Onglyza accomplished by FDA experts found that concerning issues that linked the medication to heart disease risks. The trial (the SAVOR research ), that was sponsored by AstraZeneca, had over 16,000 participants. The participants either had a background or vulnerable to developing cardiovascular disease. Some of them were awarded Onglyza, and many others received Placebo.

Talk to a lawyer today to discuss filing a Boston Onglyza Lawsuit.

The researchers monitored the participants’ health advancement for about two years. The results showed many of the patients who utilized Onglyza were hospitalized for heart failure than those who got Placebo. The Onglyza users have a 27% increased risk of cardiovascular disease, heart failure, or related complications.

The outcomes necessitated more stringent scrutiny on the medication by the FDA.

Why And What Exactly Can Be Onglyza Linked To Heart Failure?

Cardiovascular disease is one of the leading health problems that lead to the death of both women and men in the usa. The CDC claims there are almost 610,000 fatalities attributed to heart disease yearly. If you do the math, that amounts to 1 every four deaths in the USA each year.

Heart failure happens when the heart fails to pump as much blood as is required throughout the body. It’s a kind of cardiovascular disease where the body gets an insufficient supply of blood. Thus, less oxygen into its organs, thereby crippling their collective purpose. When not treated, heart failure progresses and leads to deadly health issues with deadly consequences.

For people who have type 2 diabetes and are utilizing Onglyza, the link between their health difficulties and the medication is alarming. The FDA started an investigation procedure into the drug and how it increases the probability of heart failure; this is after increased concerns across the USA. The investigation unearthed worrying issues that resulted in additional warnings of heart failure risk linked with the usage of Onglyza as well as Kombiglyze XR.

Pancreatic Cancer and Onglyza

Because of the way Onglyza stimulates the pancreas to release more insulin, that is why the medication was associated with the consumers facing a potential gain in the chance of pancreatitis and pancreatic cancer.

A study was performed in 2013 that concentrated on how DDP-4 inhibitors affected the pancreas discovered that participants who had type 2 diabetes and have been utilizing Onglyza have a higher prospect of using an enlarged pancreas. In addition, they have an elevated probability of having precancerous cellular changes in their own pancreas, suggesting a considerable possibility of developing pancreatic cancer. According to the study, it was also found that tumors (precancerous growths) are highly likely to require surgical interventions and the patients using drugs such as Onglyza showed a greater chance of desire pancreatic surgery.

The FDA hauled another drug security awake in March of 2013, saying it had been examining findings of a study that indicated the substantial likelihood of pancreatitis and precancerous cellular changes in individuals that were utilizing incretin mimetic to take care of their type 2 diabetes. Some of the drugs listed as incretin mimetics have been Nesina, Januvia, Onglyza, and Byetta.

A later study conducted in 2014 where researchers analyzed data from a significant clinical trial on Onglyza discovered no signs of pancreatic cancer or the risk of pancreatitis. They, however, recommended further research to ensure they get conclusive findings that suggest pancreatic safety regarding using incretin mimetics.

Is Onglyza Linked To Thyroid Cancer?

In June 2011, the FDA issued a security warning stating the probability of thyroid cancer from the use of Victoza.

Has There Been A Recall Of Onglyza Or Other Incretin Mimetics?

No recall has been announced, and it is unlikely for you to be issued anytime soon. The recalls seem unforthcoming, yet the fact of heart failure, cancers, and other possibly deadly health issues can’t be overlooked or swept under the rug. Vioxx was a medication that has been recalled due to causing strokes and heart attacks, among other cardiovascular problems.

The same fate is due to Onglyza along with other incretin mimetics found to increase the chance of heart failure. However, it seems that the only important measure taken for these drugs with such serious side effects is to require that the manufacturers include additional security warnings in their products’ labels. You may encounter a”black box” warning at the top of the drug’s labeling.

Are There Any Continuing Class Action Lawsuits Involving Kombiglyze, Onglyza, Or Any Incretin Mimetic?

Drug injury lawsuits are seldom filed as”class action,” where a few plaintiffs will represent the others who have cases against a drug business. Instead, you can fill such a matter separately.

Back in January 2018, the U.S Judicial Panel on Multidistrict Litigation ordered the”consolidation” of existing lawsuits filed against Kombiglyze and Onglyza from the U.S District Court for the Eastern District of Kentucky. From May 2018, there were around 100 of these cases that shaped consolidated litigation called the MDL 2809. Other lawsuits are still pending the California State Court.

  • Heart failure
  • Pancreatitis
  • Kidney problems
  • Thyroid cancer
  • Pancreatic cancer
  • Departure

Schedule a free consultation with our attorneys to review your Boston Onglyza lawsuit.

Besides the severe side effects mentioned above, Onglyza can also be connected to the following moderate to moderate health hazard:

  • Headaches
  • Urinary tract infections
  • Rashes and Infection
  • Upper respiratory tract infections

Can You File a Boston Onglyza Lawsuit Without an FDA Recall?

However, this directive has many asking why the caution was not included when the product was released ten decades back.

And when this is the current state of affairs, then it implies many of the patients that took Onglyza within the past decade were oblivious of the potential health risk. They, therefore, might have suffered serious side effects, not knowing the cause.

The legislation stipulates that drug manufacturers should be accountable for ensuring the public is informed before they launch a product to the industry. It makes them accountable for any adverse outcomes and functions to protect the general public from unnecessary health problems.

And as per the legislation, patients that took Onglyza and suffered heart failure can seek reimbursement because the pharmaceutical companies making the drug don’t give the public adequate security warnings about such a probable outcome.

Get Legal Help From An Onglyza Attorney

In the event that you or a loved one employed Onglyza and suffered heart failure, hospitalization, or your relative died due to using the drug, our dedicated class action attorneys are here to assist. We’ve represented different individuals from throughout the nation. Thus, we have a profound comprehension o how pharmaceuticals like Bristol Meyers Squibb and AstraZeneca are expected, by law, to make sure doctors and patients are fully aware of the risk connected with the use of their medications. Failure to do so implies that these manufacturers are liable for harms that people using their medications suffer.

We’ve dealt with cases related to Onglyza and have a deep understanding of its own flaws. Thus, we are your very best bet if you want to face the makers of Onglyza and win. Contact our law offices today at 855-938-0980 a totally free consultation, case review, and also find out more about your rights.

Related Articles